159 related articles for article (PubMed ID: 7608284)
1. Calcium-regulating hormones across the menstrual cycle: evidence of a secondary hyperparathyroidism in women with PMS.
Thys-Jacobs S; Alvir MJ
J Clin Endocrinol Metab; 1995 Jul; 80(7):2227-32. PubMed ID: 7608284
[TBL] [Abstract][Full Text] [Related]
2. Calcium-regulating hormones across the menstrual cycle.
Muse KN; Manolagas SC; Deftos LJ; Alexander N; Yen SS
J Clin Endocrinol Metab; 1986 Jun; 62(6):1313-6. PubMed ID: 3084541
[TBL] [Abstract][Full Text] [Related]
3. Cyclical changes in calcium metabolism across the menstrual cycle in women with premenstrual dysphoric disorder.
Thys-Jacobs S; McMahon D; Bilezikian JP
J Clin Endocrinol Metab; 2007 Aug; 92(8):2952-9. PubMed ID: 17488795
[TBL] [Abstract][Full Text] [Related]
4. Decreased central opioid activity in premenstrual syndrome: luteinizing hormone response to naloxone.
Rapkin AJ; Shoupe D; Reading A; Daneshgar KK; Goldman L; Bohn Y; Brann DW; Mahesh VB
J Soc Gynecol Investig; 1996; 3(2):93-8. PubMed ID: 8796815
[TBL] [Abstract][Full Text] [Related]
5. Cerebrospinal fluid levels of monoamine metabolites. A preliminary study of their relation to menstrual cycle phase, sex steroids, and pituitary hormones in healthy women and in women with premenstrual syndrome.
Eriksson E; Alling C; Andersch B; Andersson K; Berggren U
Neuropsychopharmacology; 1994 Nov; 11(3):201-13. PubMed ID: 7532413
[TBL] [Abstract][Full Text] [Related]
6. Plasma 25-hydroxyvitamin D and risk of premenstrual syndrome in a prospective cohort study.
Bertone-Johnson ER; Hankinson SE; Forger NG; Powers SI; Willett WC; Johnson SR; Manson JE
BMC Womens Health; 2014 Apr; 14():56. PubMed ID: 24725979
[TBL] [Abstract][Full Text] [Related]
7. Brain-derived neurotrophic factor plasma variation during the different phases of the menstrual cycle in women with premenstrual syndrome.
Cubeddu A; Bucci F; Giannini A; Russo M; Daino D; Russo N; Merlini S; Pluchino N; Valentino V; Casarosa E; Luisi S; Genazzani AR
Psychoneuroendocrinology; 2011 May; 36(4):523-30. PubMed ID: 20933336
[TBL] [Abstract][Full Text] [Related]
8. Chronic adaptation of dog parathyroid function to a low-calcium-high-sodium-vitamin D-deficient diet.
Cloutier M; Gascon-Barré M; D'Amour P
J Bone Miner Res; 1992 Sep; 7(9):1021-8. PubMed ID: 1414494
[TBL] [Abstract][Full Text] [Related]
9. Calcium-regulating hormones during the menstrual cycle.
Pitkin RM; Reynolds WA; Williams GA; Hargis GK
J Clin Endocrinol Metab; 1978 Sep; 47(3):626-32. PubMed ID: 263315
[TBL] [Abstract][Full Text] [Related]
10. Intravenous 1,25(OH)2D therapy increases the intact parathyroid hormone secretion set point in hemodialyzed patients.
Brossard JH; Roy L; Lepage R; Gascon-Barré M; D'Amour P
Miner Electrolyte Metab; 1997; 23(1):25-32. PubMed ID: 9058366
[TBL] [Abstract][Full Text] [Related]
11. Daily plasma estradiol and progesterone levels over the menstrual cycle and their relation to premenstrual symptoms.
Redei E; Freeman EW
Psychoneuroendocrinology; 1995; 20(3):259-67. PubMed ID: 7777654
[TBL] [Abstract][Full Text] [Related]
12. Relationship between symptom severity and steroid variation in women with premenstrual syndrome: study on serum pregnenolone, pregnenolone sulfate, 5 alpha-pregnane-3,20-dione and 3 alpha-hydroxy-5 alpha-pregnan-20-one.
Wang M; Seippel L; Purdy RH; Bãckström T
J Clin Endocrinol Metab; 1996 Mar; 81(3):1076-82. PubMed ID: 8772579
[TBL] [Abstract][Full Text] [Related]
13. Age effects of follicle-stimulating hormone and pulsatile luteinizing hormone secretion across the menstrual cycle of premenopausal women.
Reame NE; Kelche RP; Beitins IZ; Yu MY; Zawacki CM; Padmanabhan V
J Clin Endocrinol Metab; 1996 Apr; 81(4):1512-8. PubMed ID: 8636360
[TBL] [Abstract][Full Text] [Related]
14. Relationship between symptom severity and hormone changes in women with premenstrual syndrome.
Hammarbäck S; Damber JE; Bäckström T
J Clin Endocrinol Metab; 1989 Jan; 68(1):125-30. PubMed ID: 2491857
[TBL] [Abstract][Full Text] [Related]
15. Changes in biochemical markers of osteoblastic activity during the menstrual cycle.
Nielsen HK; Brixen K; Bouillon R; Mosekilde L
J Clin Endocrinol Metab; 1990 May; 70(5):1431-7. PubMed ID: 2110577
[TBL] [Abstract][Full Text] [Related]
16. Distribution of positive moods in women with the premenstrual syndrome and in normal women.
Metcalf MG; Livesey JH
J Psychosom Res; 1995 Jul; 39(5):609-18. PubMed ID: 7490695
[TBL] [Abstract][Full Text] [Related]
17. Differential response to estrogen challenge test in women with and without premenstrual dysphoria.
Eriksson O; Bäckström T; Stridsberg M; Hammarlund-Udenaes M; Naessén T
Psychoneuroendocrinology; 2006 May; 31(4):415-27. PubMed ID: 16359822
[TBL] [Abstract][Full Text] [Related]
18. Effect of menstrual cycle phase on neuroendocrine and behavioral responses to the serotonin agonist m-chlorophenylpiperazine in women with premenstrual syndrome and controls.
Su TP; Schmidt PJ; Danaceau M; Murphy DL; Rubinow DR
J Clin Endocrinol Metab; 1997 Apr; 82(4):1220-8. PubMed ID: 9100599
[TBL] [Abstract][Full Text] [Related]
19. Does the plasma concentration of 25-hydroxyvitamin D determine the level of 1,25-dihydroxyvitamin D in primary hyperparathyroidism?
Frølich A; Storm T; Thode J
Miner Electrolyte Metab; 1996; 22(4):203-6. PubMed ID: 8807622
[TBL] [Abstract][Full Text] [Related]
20. CSF and endocrine studies of premenstrual syndrome.
Parry BL; Gerner RH; Wilkins JN; Halaris AE; Carlson HE; Hershman JM; Linnoila M; Merrill J; Gold PW; Gracely R
Neuropsychopharmacology; 1991 Sep; 5(2):127-37. PubMed ID: 1930615
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
